Katherine Yang, PharmD, MPH
Professor
Clinical Pharmacy
School of Pharmacy
Kathy Yang, Pharm.D., MPH is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy at the University of California (UCSF) School of Pharmacy and an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in the treatment of multi-drug resistant infections, particularly gram negative bacteria such as Pseudomonas aeruginosa.
Show full bio (60 words) Hide full bio
Her area of research focuses on the pharmacodynamic optimization of antibiotics for the treatment of biofilm-mediated infections such as cystic fibrosis.
Within the School of Pharmacy, Dr. Yang is involved in multiple aspects of the curriculum related to infectious diseases. Dr. Yang is also the co-director of Foundations, the first course of the Pharm.D. curriculum.
Awards
Show all (2) Hide
- Fellow, California Society of Health-Systems Pharmacists, 2006
- Long Prize for Excellence in Teaching, UCSF School of Pharmacy, 2005
Education & Training
Show all (4) Hide
- MPH Public Health University of California, Berkeley 2001
- Residency in Infectious Diseases Infectious diseases University of California, San Francisco 2000
- Residency in Pharmacy Practice Pharmacy University of California, San Francisco 1999
- Pharm.D. Pharmacy University of California, San Francisco 1998
Interests
Show all (7) Hide
- Pseudomonas aeruginosa
- pharmacokinetics
- biofilm
- antibiotic resistance
- antimicrobial stewardship
- cystic fibrosis
- pharmacodynamics
Websites
Show all (1) Hide
- UCSF Department of Clinical Pharmacy Profile (clinicalpharmacy.ucsf.edu)
Grants and Projects
Show all (1) Hide
Publications (21)
Top publication keywords:
Pneumonia, BacterialCystic FibrosisBiofilmsVoriconazolePneumonia, Ventilator-AssociatedTobramycinLong QT SyndromeAnti-Bacterial AgentsNitrilesThienamycinsTriazolesPseudomonas aeruginosaAdenosine MonophosphateCulture MediaAlanine
-
Mathematical Modeling of Biofilm Structures Using COMSTAT Data.
Computational and mathematical methods in medicine 2017 Verotta D, Haagensen J, Spormann AM, Yang K -
Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
The Journal of antimicrobial chemotherapy 2017 Haagensen J, Verotta D, Huang L, Engel J, Spormann AM, Yang K -
New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.
Antimicrobial agents and chemotherapy 2015 Haagensen JA, Verotta D, Huang L, Spormann A, Yang K -
Pragmatic Mentoring Strategies for the Busy Surgeon Scientist.
Journal of surgical education 2022 Highet A, Kendrick DE, Bandeh-Ahmadi H, Vitous A, Yang K, Ernst C, George BC -
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Infection control and hospital epidemiology 2021 Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB
Show all (16 more) Hide
-
What Do We Know About Remdesivir Drug Interactions?
Clinical and translational science 2020 Yang K -
Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid.
Journal of analytical methods in chemistry 2018 Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K -
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Transplant infectious disease : an official journal of the Transplantation Society 2017 Trang TP, Hanretty AM, Langelier C, Yang K -
Determination of meropenem in bacterial media by LC-MS/MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2014 Huang L, Haagensen J, Verotta D, Lizak P, Aweeka F, Yang K -
Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.
International journal of antimicrobial agents 2011 Fricks-Lima J, Hendrickson CM, Allgaier M, Zhuo H, Wiener-Kronish JP, Lynch SV, Yang K -
Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients.
American journal of infection control 2010 Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS -
An Evidenced-based Practice in Critical Care
Epidemiology and management of antibiotic resistance in the ICU 2010 Yang, K MacDougall C Wiener-Kronish J -
Variation in outpatient antibiotic prescribing in the United States.
The American journal of managed care 2009 Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R -
Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures.
The Annals of pharmacotherapy 2008 Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J -
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection.
Critical care medicine 2008 Zhuo H, Yang K, Lynch SV, Dotson RH, Glidden DV, Singh G, Webb WR, Elicker BM, Garcia O, Brown R, Sawa Y, Misset B, Wiener-Kronish JP -
Culture-Independent Bacterial Population Analysis - Clinical Implications for Respiratory and Other Infections
Current Respiratory Medicine Reviews 2008 Lynch SV Yang K Brodie EL MacDougall C Andersen G Wiener-Kronish JP -
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.
The Annals of pharmacotherapy 2007 Yang K, Guglielmo BJ -
Expanding the Role of the Pharmacist in Public Health
California Journal of Health-Systems Pharmacy 2006 Yang K Youmans S -
Utilization of Community Pharmacies: Implications for Health Care Delivery
Harvard Health Policy Review 2006 Youmans S Vogt E Yang K -
Blueprints Notes and Cases
Pharmacology 2003 Yang K Graff L Caughey A -
Patient education for H pylori: who benefits?
The Western journal of medicine 2002 Yang K, Guglielmo BJ